Circulation. 2006;113:1817
(Circulation. 2006;113:1817.)
© 2006 American Heart Association, Inc.
Issue Highlights
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
A TAILORED APPROACH TO CATHETER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION, by Oral et al.
|
|---|
Paroxysmal atrial fibrillation is a complex arrhythmia initiated
by rapid "triggering" foci and likely perpetuated by the triggers
and abnormal conduction in regions outside the triggering sites.
Although the location of this arrhythmogenic substrate varies
among patients, a simple anatomic ablation approach encircling
the pulmonary venous regions is often effective, but not always
easy to achieve. Oral and colleagues evaluated a tailored approach
to ablation, sequentially targeting areas identified as potentially
arrhythmogenic on the basis of rapid electrical activity, seeking
to achieve an electrophysiological end point of noninducibility
of atrial fibrillation. The results are comparable to those
of some studies utilizing purely anatomic approaches and show
that a tailored approach can achieve efficacy without extensive
anatomic ablation. Such an approach can avoid ablation in the
high-risk area adjacent to the esophagus. The study illustrates
the heterogeneity of this arrhythmia and supports continued
evaluation of ablation strategies. See p 1824.
 |
ß2-ADRENERGIC RECEPTOR GENETIC VARIANTS AND RISK OF SUDDEN CARDIAC DEATH, by Sotoodehnia et al.
|
|---|
Sudden cardiac death is a major cause of death in developed
countries and results in almost one half million deaths per
year in the United States. Both experimental and clinical observations
suggest that ß2 adrenergic receptors partially mediate
sympathetic activation. Hence the ß2 adrenergic receptor
gene (B2AR) represents an attractive candidate gene for susceptibility
to sudden cardiac death. Sotoodehnia and colleagues examined
the association of two polymorphisms in the B2AR gene (Gly16Arg
and Gln27Glu) with sudden cardiac death in the community-based
Cardiovascular Health Study. They report that Gln27 homozygotes
had a 58% increased risk of sudden cardiac death (nominal
P. . . [Full Text of this Article]